| Net Cash Provided by (Used in) Operating Activities |
$72,494,000 |
USD |
-527% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$83,578,000 |
USD |
1439% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
450,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
46,588,608 |
shares |
16% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$11,084,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$20,635,000 |
USD |
-27% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$7,189,000 |
USD |
8.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$6,584,000 |
USD |
-35% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$6,347,000 |
USD |
-340% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$316,000 |
USD |
888% |
Q4 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$5,337,000 |
USD |
-254% |
Q1 2025 |
Q1 2025 |
| Current Income Tax Expense (Benefit) |
$2,181,000 |
USD |
-236% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$782,007,000 |
USD |
13% |
Q4 2025 |
FY 2025 |
| Current State and Local Tax Expense (Benefit) |
$633,000 |
USD |
71% |
Q1 2025 |
Q1 2025 |
| Current Federal Tax Expense (Benefit) |
$3,543,000 |
USD |
7952% |
Q1 2025 |
Q1 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$1,010,000 |
USD |
-24% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$37,673,000 |
USD |
33% |
Q1 2024 |
Q1 2024 |